|Cancer is currently the fourth leading cause of death in Germany. Chemotherapy is a major pillar of cancer treatment. There is a need to identify new active substances with anti-tumorigenic potential, on the one hand to reduce side effects and on the other hand to optimize the personalized therapy concept. This thesis deals with the identification of potential new antitumor agents by establishing valid screening systems. Furthermore, new metastatic markers are identified using metabolic methods.